PBR Life Sciences is a healthcare data analytics company headquartered in London, United Kingdom. Founded in 2015 by Ayodeji Alaran, the company focuses on leveraging big data and artificial intelligence to transform the healthcare sector, particularly in Africa. PBR Life Sciences has raised over $1.12 million, with significant investments from Launch Africa, Techstars, and other venture partners. The company's innovative solutions are aimed at providing pharmaceutical giants such as Sanofi with critical market insights to enhance product pricing, demand forecasting, and development tailored to the African market.
Attribute | Information |
---|---|
Founding Date | 2015 |
Headquarters | London, United Kingdom |
Founders | Ayodeji Alaran |
Revenue | Not publicly disclosed |
Profits | Not publicly disclosed |
Key Investors | Launch Africa, Techstars, ARM Labs, Microtraction |
Industry | Healthcare Data Analytics |
Number of Employees | 31 |
PBR Life Sciences was founded by Ayodeji Alaran in 2015 in the United Kingdom. Initially, the company focused on healthcare services, but in 2021, it pivoted towards data analytics and big data solutions. The strategic shift was driven by the need to address the inadequate real-world healthcare data in African markets, which presents challenges in pharmaceutical production and decision-making. By aggregating anonymized data from numerous sources, PBR aimed to enhance the efficiency and accuracy of market forecasts and strategies.
PBR Life Sciences is primarily focused on offering data-driven solutions that enhance the strategic capabilities of pharmaceutical companies. The business model revolves around providing real-world data through platforms such as "PharmacyMetrics," a dashboard tool that supports business performance evaluation for pharmacies. Notable achievements include:
Currently, PBR Life Sciences operates across various African countries including Nigeria, Ghana, and Kenya, with plans for further expansion. It delivers comprehensive data analytics services to pharmaceutical giants, consulting firms, NGOs, and multilateral organizations. The company has a distinctive advantage in using AI and data analytics to bridge healthcare gaps in emerging markets, notably enhancing pharmaceutical strategies through data-driven insights.
PBR Life Sciences offers a suite of products aimed at optimizing healthcare data utilization:
PBR Life Sciences specializes in analytics that transform vast amounts of health data into actionable insights. This involves using advanced AI techniques to provide clients with market forecasts, trend analyses, and strategic insights that support decision-making processes in the healthcare sector.
PBR Life Sciences is positioned as a transformative entity in the healthcare analytics industry, with a strong focus on integrating AI and big data into pharmaceutical strategy planning in Africa. With a robust network of investors and a clear strategic vision, PBR Life Sciences stands to significantly impact the future of data-driven healthcare solutions across emerging markets. The company's innovative approach and collaborations promise further expansion and a strong trajectory in the global life sciences field.